Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3 Business Technology Group Regulatory News (KBT)

  • There is currently no data for KBT

Contract Wins

25 Feb 2005 07:00

K3 Business Technology Group PLC25 February 2005 K3 BUSINESS TECHOLOGY GROUP PLC ("K3") ANNOUNCES NEW CONTRACTS WINS K3, the IT solutions provider to the manufacturing, distribution and retailsectors, is pleased to announce that its subsidiaries, K3 Landsteinar and K3Elucid ("Elucid"), have won new contracts with a total value of approximately£1.05m. K3 Landsteinar, acquired in October 2004, has secured three new contracts tosupply its retail management software, worth a total of £750,000. The largest isa £300,000 deal with a leading independent homeware and fashion retailer. Thesecond, worth £250,000, provides a complete business solution for a retailer ofbeauty products. The third is a contract for approximately £200,000 with ahigh-street electronics retailer. Elucid, which supplies warehousing and distribution software and was acquired inApril 2004, has signed a contract worth £300,000 with Scotts of Stow, themail-order specialist. Elucid is to install a complete distribution solution,encompassing all the retailer's sales channels, on-line, catalogue and stores. Andy Makeham, CEO, of K3 commented, "I am delighted to announce these new contract wins. They demonstrate thestrength of K3 Landsteinar's and Elucid's product offering and confirms our viewthat both acquisitions have excellent growth prospects." Enquiries: K3 Business Technology Group T: 01282 864111Andy Makeham, Chief ExecutiveDavid Bolton, Finance Director Biddicks T: 020 7448 1000Katie Tzouliadis This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Apr 20207:00 amRNSLoan Funding Secured and Update on Subsidiary
24th Mar 20207:00 amRNSDelay to Final Results
21st Feb 202011:28 amRNSHolding(s) in Company
18th Feb 20203:10 pmRNSDirector/PDMR Shareholding
17th Feb 202012:32 pmRNSBoard Appointment
6th Feb 20204:13 pmRNSBoard Changes
28th Oct 20196:15 pmRNSPDMR Announcement
24th Oct 20192:09 pmRNSDirector/PDMR Shareholding
22nd Oct 20192:00 pmRNSPrice Monitoring Extension
22nd Oct 20197:00 amRNSTrading update
12th Jul 20194:41 pmRNSPDMR Announcement
9th Jul 20197:00 amRNSInterim Results
18th Jun 20197:00 amRNSTrading Update
23rd May 20198:48 amRNSPDMR Announcement
22nd May 20192:05 pmRNSResult of AGM
19th Mar 20197:00 amRNSFinal Results
8th Feb 20192:42 pmRNSPDMR Dealings
22nd Jan 20191:06 pmRNSHolding(s) in Company
17th Dec 20187:00 amRNSTrading Update
29th Oct 20183:05 pmRNSHolding(s) in Company
20th Aug 20186:15 pmRNSHolding(s) in Company
9th Jul 20187:00 amRNSInterim Results
13th Jun 201810:44 amRNSHolding(s) in Company
11th Jun 20187:00 amRNSContracts Wins
7th Jun 20187:00 amRNSCapital Markets Afternoon & Notice of Results
30th May 201811:02 amRNSResult of AGM
30th May 20187:00 amRNSAGM Statement
6th Apr 20183:40 pmRNSHolding(s) in Company
5th Apr 20184:36 pmRNSPDMR Dealings
27th Mar 20187:00 amRNSFinal Results (17 months)
5th Mar 20183:48 pmRNSHolding(s) in Company
5th Jan 20189:50 amRNSHolding(s) in Company
27th Dec 20172:19 pmRNSDirector/PDMR Shareholding
12th Dec 20177:00 amRNSTrading Update
27th Sep 20177:00 amRNSSecond Interim Results
26th Sep 201711:52 amRNSHolding(s) in Company
18th Sep 201711:17 amRNSHolding(s) in Company
8th Aug 20173:55 pmRNSHolding(s) in Company
6th Jul 20175:25 pmRNSHolding(s) in Company
6th Jul 201710:48 amRNSPDMR Shareholding
6th Jul 20179:05 amRNSHolding(s) in Company
5th Jul 20171:17 pmRNSHolding(s) in Company
4th Jul 201711:41 amRNSReplacement:Result of General Meeting
4th Jul 201711:11 amRNSSIP Announcement
4th Jul 201711:06 amRNSResult of General Meeting
4th Jul 201710:36 amRNSHolding(s) in Company
4th Jul 20177:00 amRNSSigning of Facility Amendment Agreement
30th Jun 20177:00 amRNSResult of Open Offer
12th Jun 201712:58 pmRNSResults of Proposed Placing
12th Jun 20177:00 amRNSFundraising & Board Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.